Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab (P102)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02013154
Recruitment Status : Completed
First Posted : December 17, 2013
Last Update Posted : September 10, 2021
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Leap Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 19, 2019
Actual Study Completion Date : January 11, 2021